SEC Filings
Vir Biotechnology Adds Cancer Immunotherapy Researcher Suzanne Topalian As Ninth Director
Vir's board grows from eight to nine members, and Topalian also joins the Science and Technology Committee.
SEC Filings
Vir's board grows from eight to nine members, and Topalian also joins the Science and Technology Committee.
SEC Filings
A new $675.0 million term loan funded the payout after holders converted nearly all of the $287.5 million in notes.
SEC Filings
The non-binding bid is an approximate 20% premium to the October 27 close, and Trian plans to roll over its roughly 16.3% stake.
SEC Filings
The board says the proxy adviser's dilution model assumes every evergreen share is issued, ahead of a November 3 shareholder vote.
SEC Filings
Wisconsin Power and Light and Interstate Power and Light can borrow at a Treasury rate plus 37.5 basis points, but every advance has conditions.
SEC Filings
The fiber builder's annual impairment review is unfinished as interest expense climbs to $29.6 million and capital spending guidance rises.
SEC Filings
A $6.25 million legal settlement and a parts buildup drained cash, and the $2 million credit line now matures December 11, 2026.
SEC Filings
Robert Keane's fiscal 2026 pay fell to about $9 million, while older share-price awards lapsed unearned for the first time.
SEC Filings
Inventory and payables swelled in the September quarter while cash burn narrowed and a note maturity moved into current liabilities.
SEC Filings
Holders can pay the $3.00 exercise price with 2028 convertible notes at face value, and Enovix also bought back $100 million of 2030 notes.
SEC Filings
The auto-parts retailer's proxy also shows its CFO resigning and the board keeping a director who now runs QVC Group.
SEC Filings
The cancer-drug developer's debt covenant offers three ways to pass as its first product, TUDRIQEV, reaches patients.